Score Overview
See the full market ranking โ
Krystal Biotech Inc fundamental performance
Across Krystal Biotech Inc's full reported history, from 2017 to 2025, revenue grew from $ 0.00 to $ 389M and net income went from -$ 7M to $ 204M. Revenue increased in 56% of the years measured; net income in 44%.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 332.86 | โ |
1 Year2025-08-12 | $ 143.62 | 131.76% |
5 Years2021-08-12 | $ 56.26 | 491.65% |
All Time2017-09-20 | $ 10.64 | 31x |
| Period | Last Price2026-08-12 | 1 Year2025-08-12 | 5 Years2021-08-12 | All Time2017-09-20 |
|---|---|---|---|---|
| Price | $ 332.86 | $ 143.62 | $ 56.26 | $ 10.64 |
| Return | โ | 131.76% | 491.65% | 31x |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2026 | $ 440M | $ 241M | $ 845M |
| 2025 | $ 389M | $ 204M | $ 827M |
| 2024 | $ 290M | $ 89M | $ 597M |
| 2023 | $ 50M | $ 10M | $ 532M |
| 2022 | $ 0.00 | -$ 139M | $ 379M |
| 2021 | $ 0.00 | -$ 69M | $ 438M |
| 2020 | $ 0.00 | -$ 32M | $ 271M |
| 2019 | $ 0.00 | -$ 19M | $ 193M |
| 2018 | $ 1M | -$ 10M | $ 111M |
| IPO2017 | $ 0.00 | -$ 7M | $ 49M |
Explore beyond KRYS
You're looking at Krystal Biotech Inc. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score โ 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
